Home  Media Press releases
|
|
|
| 6 March 2008 | 2008-03-06T00:00:00.0000000-00:00 |
| AstraZeneca Issues 2007 Annual Report
AstraZeneca has today published its Annual Report and Form 20-F Information 2007. The Report is available as a dedicated website at:
www.astrazeneca.com/annualreport2007 (which includes a downloadable PDF version) and as a printed document. Our summary corporate responsibility (CR) report has been integrated into the Report and full CR information continues to be available online at: www.astrazeneca.com/responsibility.
| AstraZeneca has today also published its Notice of Annual General Meeting 2008 and Shareholders' Circular in which is set out the resolutions that will be put before the Company's members at its Annual General Meeting on 24 April 2008. The date of the 2008 Annual General Meeting coincides with the announcement of the First Quarter Results for 2008.
AstraZeneca is a major international healthcare business engaged in research, development, manufacturing and marketing of prescription pharmaceuticals and supplier for healthcare services. AstraZeneca is one of the world's leading pharmaceutical companies with healthcare sales of US $29.55 billion and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infection product sales. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good Index.
Media Enquiries:
Steve Brown +44 207 304 5033 (24 hours)
Chris Sampson +44 20 7304 5130 (24 hours)
Neil McCrae +44 207 304 5045 (24 hours)
Investor Enquiries UK:
Jonathan Hunt +44 207 304 5087 mob: +44 7775 704032
Mina Blair +44 20 7304 5084 mob: +44 7718 581021
Karl Hard +44 207 304 5322 mob: +44 7789 654364
Investor Enquiries US:
Ed Seage +1 302 886 4065 mob: +1 302 373 1361
Jorgen Winroth +1 212 579 0506 mob: +1 917 612 4043
Peter Vozzo (MedImmune) +1 301 398 4358 mob: +1 301 252 7518
|
|
|